NLS Pharmaceutics Ltd. - Common Shares (NQ: NLSP )
2.260
-0.040
(-1.74%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
All News about NLS Pharmaceutics Ltd. - Common Shares
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2024/06/20/xrdDAFl-HSvCpE2-j6755793051000407071-t23_0.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2024/05/pltr1600-5.png)
![](https://investorplace.com/wp-content/uploads/2020/07/medicine-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/20/wall-street-ai15.png?width=1200&height=800&fit=crop)
Dow Edges Lower; US Current Account Deficit Widens In Q1
June 20, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://investorplace.com/wp-content/uploads/2020/02/medicine-iv-drip.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/20/movers-image_11.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/18/Movers_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/06/18/Stocks-Photo-by-Jirapong-Manustrong-on-S.jpeg?width=1200&height=800&fit=crop)
US Stocks Mixed; Retail Sales Increase 0.1% In May
June 18, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/02/video-player-digital-entertainment.png)
![](https://investorplace.com/wp-content/uploads/2023/02/awin1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2019/07/internet-of-things-large.jpg)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/18/movers-image.jpeg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq
February 23, 2024
Via ACCESSWIRE
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Notice of Deficiency with Nasdaq Continued Listing Requirements
January 12, 2024
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
NLS Pharmaceutics CEO Issues Letter to Shareholders
December 29, 2023
Via ACCESSWIRE
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.